Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Saturday, November 23, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Saturday, November 23, 2024 | Latest Paper
Subscribe Now

TRENDING:

Matthew Herder

Matthew Herder is an adviser with EvidenceNetwork.ca and associate professor, health law institute, faculties of medicine and law, Dalhousie University.

The NDP-backed pharmacare plan is a corporate handout as written

  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

The NDP-backed pharmacare plan is a corporate handout as written

  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

It’s time to think beyond national pharmacare

  • Recently, federal and provincial health ministers agreed to create a working group to explore how to improve Canadians’ access to pharmaceutical drugs. In the
Opinion | BY MATTHEW HERDER | March 7, 2016

It’s time to think beyond national pharmacare

Opinion | BY MATTHEW HERDER | March 7, 2016
  • Recently, federal and provincial health ministers agreed to create a working group to explore how to improve Canadians’ access to pharmaceutical drugs. In the

It’s time to think beyond national pharmacare

Opinion | BY MATTHEW HERDER | March 7, 2016
  • Recently, federal and provincial health ministers agreed to create a working group to explore how to improve Canadians’ access to pharmaceutical drugs. In the
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu